Viveve Medical raises $3.2m

Viveve Medical (NSDQ:VIVE) filed an SEC Form D yesterday to confirm the sale of more than $3.2 million in options, warrants and other rights to acquire other securities.
The company made the first sale in the offering on April 20 and has now sold the total offering amount of $3,225,875. There is a sales commission worth $216,206 and a $40,000 reimbursement of the placement agent’s legal expenses, according to the filing.
In total, nine investors contributed to the financing. Viveve Medical did not specify an intended use of the proceeds in the filing.
Englewood, Colo.–based Viveve’s eponymous device uses cryogen-cooled monopolar radiofrequency tech designed to treat gynecological conditions.
At the end of last year, the company priced a $10 million offering, adding to a $20 million offering in December 2018 and a $6.8 million offering in the face of delisting in August 2019.
Original Article: (https://www.massdevice.com/viveve-medical-raises-3-2m/)